Clinical characterization and founder effect analysis in Chinese amyotrophic lateral sclerosis patients with SOD1 common variants

被引:0
|
作者
Wang, Pei-Shan [1 ,2 ,3 ,4 ]
Yang, Xin-Xia [1 ,2 ,3 ,4 ]
Wei, Qiao [1 ,2 ,3 ,4 ]
Lv, Yong-Ting [1 ,2 ,3 ,4 ]
Wu, Zhi-Ying [1 ,2 ,3 ,4 ,5 ]
Li, Hong-Fu [1 ,2 ,3 ,4 ,6 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Med Genet, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Ctr Rare Dis, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[3] Zhejiang Univ, Sch Med, Dept Neurol, Hangzhou, Peoples R China
[4] Zhejiang Univ, Sch Med, Key Lab Med Neurobiol Zhejiang Prov, Hangzhou, Peoples R China
[5] Nanhu Brain Comp Interface Inst, Hangzhou, Peoples R China
[6] Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine Int, Hangzhou, Peoples R China
关键词
Amyotrophic lateral sclerosis; SOD1; Chinese; common variants; founder effect; aggregation; MOTOR-NEURON DISEASE; HIS46ARG MUTATION; TRANSGENIC MICE; H46R MUTATION; ALS; FEATURES; FAMILY; GENES; SUBSTITUTION;
D O I
10.1080/07853890.2024.2407522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In the Asian population, SOD1 variants are the most common cause of amyotrophic lateral sclerosis (ALS). To date, more than 200 variants have been reported in SOD1. This study aimed to summarize the genotype-phenotype correlation and determine whether the patients carrying common variants derive from a common ancestor. Methods: A total of 103 sporadic ALS (SALS) and 11 familial ALS (FALS) probands were included and variants were screened by whole exome sequencing. Functional analyses were performed on fibroblasts derived from patients with SOD1 p.V48A and control. Haplotype analysis was performed in the probands with p.H47R or p.V48A and their familial members. Results: A total of 25 SOD1 variants were identified in 44 probands, in which p.H47R, p.V48A and p.C112Y variants were the most common variants. 94.3% and 60% of patients with p.H47R or p.V48A had lower limb onset with predominant lower motor neurons (LMNs) involvement. Patients with p.H47R had a slow progression and prolonged survival time, while patients with p.V48A exhibited a duration of 2-5 years. Patients with p.C112Y variant showed remarkable phenotypic variation in age at onset and disease course. SOD1V48A fibroblasts showed mutant SOD1 aggregate formation, enhanced intracellular reactive oxygen species level, and decreased mitochondrial membrane potential compared to the control fibroblast. Haplotype analysis showed that seven families had two different haplotypes. p.H47R and p.V48A variants did not originate from a common founder. Conclusions: Our study expanded the understanding of the genotype-phenotype correlation of ALS with SOD1 variants and revealed that the common p.H47R or p.V48A variant did not have a founder effect.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis
    P. Wicks
    S. Abrahams
    B. Papps
    A. Al-Chalabi
    C. E. Shaw
    P. N. Leigh
    L. H. Goldstein
    Journal of Neurology, 2009, 256 : 234 - 241
  • [32] Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China
    Hou, Lihua
    Jiao, Bin
    Xiao, Tingting
    Zhou, Lu
    Zhou, Zhifan
    Du, Juan
    Yan, Xinxiang
    Wang, Junling
    Tang, Beisha
    Shen, Lu
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis
    Coutinho Pereira, Gabriel Rodrigues
    Abrahim Vieira, Barbara de Azevedo
    De Mesquita, Joelma Freire
    PLOS ONE, 2021, 16 (02):
  • [34] SOD1-ALS-Browser: a web-utility for investigating the clinical phenotype in SOD1 amyotrophic lateral sclerosis
    Spargo, Thomas P.
    Opie-Martin, Sarah
    Hunt, Guy P.
    Kalia, Munishikha
    Al Khleifat, Ahmad
    Topp, Simon D.
    Shaw, Christopher E.
    Al-Chalabi, Ammar
    Iacoangeli, Alfredo
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2023, 24 (7-8) : 736 - 745
  • [35] Amyotrophic Lateral Sclerosis with SOD1 Mutation Presenting with Progressive Cerebellar Ataxia
    Sequeira, Marta
    Godinho, Filipe
    Lourenco, Joao
    CEREBELLUM, 2024, 23 (04) : 1702 - 1704
  • [36] Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations
    Tokuda, Eiichi
    Furukawa, Yoshiaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [37] SOD1 gene mutations in patients with amyotrophic lateral sclerosis: Potential of method of molecular modeling
    Lysogorskaia, E. V.
    Rossokhin, A. V.
    Abramycheva, N. Yu.
    Zakharova, M. N.
    Illarioshkin, S. N.
    MOLECULAR BIOLOGY, 2013, 47 (05) : 751 - 757
  • [38] Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis
    Vehvilainen, Piia
    Koistinaho, Jari
    Goldsteins, Gundars
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [39] SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis
    Park, Fijulien H.
    Elpers, Christiane
    Reunert, Janine
    McCormick, Michael L.
    Mohr, Julia
    Biskup, Saskia
    Schwartz, Oliver
    Rust, Stephan
    Grueneberg, Marianne
    Seelhoefer, Anja
    Schara, Ulrike
    Boltshauser, Eugen
    Spitz, Douglas R.
    Marquardt, Thorsten
    BRAIN, 2019, 142 : 2230 - 2237
  • [40] A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosis
    Lum, Jeremy S.
    Brown, Mikayla L.
    Farrawell, Natalie E.
    Bartlett, Rachael
    Chisholm, Christen G.
    Gorman, Jody
    Dosseto, Anthony
    Dux, Florian
    McInnes, Lachlan E.
    Ecroyd, Heath
    McAlary, Luke
    Crouch, Peter J.
    Donnelly, Paul S.
    Yerbury, Justin J.
    EBIOMEDICINE, 2025, 115